Kairos Venture Investments, LLC
SEC exempt reporting adviser (venture capital exemption).
- HQ
- CA
Kairos Venture Investments invests early in leading scientific discoveries and works to commercialize them into viable businesses. It backs scientists, engineers and entrepreneurs with capital and hands-on support. Its portfolio spans areas such as therapeutics, medical devices, materials, lasers, aerospace and healthcare data, including Provivi, KMLabs and Clearsense. Jim Demetriades is CEO and Founder.
New fund likely raising soon
The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Not stated | Not enough dated deals | Series A, Seed, Series B |
| Sectors | Not stated | Not enough dated deals | Biotech, Healthtech, Hardware, Manufacturing |
| Regions | Not stated | Not enough dated deals | CA, NJ, NY |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 2015 | 2 | Advanced materials, Agtech, Biotech |
| 2016 | 7 | Healthtech, Biotech, AI applications |
| 2017 | 17 | Biotech, Healthtech, Hardware |
| 2018 | 5 | Biotech, Hardware, Climate hardware |
| 2019 | 11 | Biotech, Hardware, Foodtech |
| 2020 | 2 | Devtools, Logistics, Manufacturing |
Stage mix over time
- Pre-seed
- Seed
- Series A
- Series B
- Growth
| Year | Pre-seed | Seed | Series A | Series B | Growth |
|---|---|---|---|---|---|
| 2015 | 0 | 0 | 2 | 0 | 0 |
| 2016 | 0 | 0 | 7 | 0 | 0 |
| 2017 | 0 | 12 | 2 | 1 | 0 |
| 2018 | 0 | 2 | 3 | 0 | 0 |
| 2019 | 0 | 2 | 3 | 4 | 1 |
| 2020 | 0 | 0 | 0 | 0 | 1 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Kairos Venture Partners III, L.P. | 2020 | $44.51M to $250M (Form D) | Follow-ons only |
03 · People across funds
- James Demetriades, Mr. Demetriades is the manager of the general partner and the investment manager of the Issuer.
Kairos Venture Partners III, L.P. (Named on Form D)
- Jim Demetriades, CEO and Founder
- Josh Palmer, PhD, Principal, Physical Sciences Investments
- Stephanie Kawecki, PhD, Investment Associate, Life Sciences
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- HTTP://WWW.KAIROSVENTURES.COM
- https://www.kairosventures.com/contact/
- https://www.kairosventures.com/team
- https://www.kairosventures.com/portfolio
- https://www.kairosventures.com/about
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 25, 2026